Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
TikTok has a fake weight loss drug problem, and it’s hitting women the hardest. A new report from the gender-justice group UltraViolet found more than 200 accounts on the platform that appeared to break TikTok’s own rules. These accounts were selling GLP-1 products without any real oversight. Many claimed to be medical spas. In reality, they were fronts for unauthorized or outright fake medications.
So how did this happen? Part of the answer traces back to a policy change. In September 2025, TikTok quietly loosened parts of its community guidelines. Those guidelines used to explicitly block gray and black market sales. They also used to discourage sellers from pushing buyers toward off platform deals and private messages. Once those restrictions eased, sellers had more room to operate.
TikTok did eventually remove some of the flagged accounts, but not many. Only about 30 percent were taken down. Nobody knows exactly why the rest disappeared or stayed up.
Real GLP-1 drugs, like Ozempic, Wegovy, and Mounjaro, are FDA-approved. Doctors prescribe them for type 2 diabetes, and in some cases, for weight management. They work by mimicking a hormone your body already makes, one that helps control blood sugar and appetite.
The products showing up in this gray market are a different story. Things like GLP-1 patches and powdered “research grade” compounds have never gone through FDA testing. Nobody has verified their safety. Nobody has confirmed what’s actually in them.
Cost is a big reason people go looking for alternatives in the first place. A month’s supply of a real GLP-1 drug typically runs between $936 and $1,023 in the US, and that price puts it out of reach for a lot of patients. Insurance doesn’t always help either, since many large employer plans still don’t cover these drugs for weight loss.
There was a brief window where access got easier. Back in 2022, a shortage led the FDA to let compounding pharmacies step in and make their own versions. But once the shortage passed, that allowance went away. Access tightened right back up, and demand didn’t slow down.
That gap between demand and supply is exactly what gray market sellers have exploited. And according to the UltraViolet report, they’re targeting women specifically. Sixty-five percent of the flagged accounts used women in their profile photos, some of which looked AI-generated. The marketing leaned heavily on sexualized imagery, playing directly into insecurities around weight and appearance.
The consequences go beyond wasted money. Buyers who connect with sellers through DMs or third-party apps often end up with nothing. Sometimes they get a package, but it’s not what they ordered. In one especially serious case, a woman ended up hospitalized with acute liver failure after using a GLP-1 product she found through social media.
Unregulated compounds carry real risks. Dosing can be wildly inconsistent. Contamination is possible. Nobody can say for certain how these substances behave in the body, because they’ve skipped every safety check that legitimate drugs go through.
Platforms are supposed to police this kind of content, but enforcement clearly has gaps. Sellers keep finding ways back in, even after getting flagged or removed. Regulators like the FDA can pursue action against illegal drug sales, but chasing down anonymous accounts across borders is no easy task.
If you’re considering a GLP-1 medication, the safest path is still the boring one: talk to a licensed doctor and fill your prescription through a real pharmacy. Skipping that step to save money or dodge a doctor’s visit is exactly how people end up scammed, or worse.
Until access improves and moderation catches up, this gray market isn’t going anywhere. Demand is too high, and the loopholes are too easy to find.
